ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid Tumors.

Jessica J Tao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.